TMO Financial Facts

Total revenues: 3.47B
Operating Income: 455M
See Full Income Statement

Total Assets: -51.45B
Treasury stock at cost, 24,023,446 and 10,409,268 shares: -412.2M
See Full Balance Sheet

Thermo Fisher Scientific, Inc. (TMO) Earnings

  |   Expand Research on TMO
Next EPS Date 4/25/14 *Est. EPS Growth Rate +5.1% *Last Qtr.
Average EPS % Beat Rate +3.2% Revenue Growth Rate +6.4% *Last Qtr.
Average % Move 1-Wk after EPS +1.3% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
10/27/10 Q310 $0.90$0.83 +$0.07N/AN/A N/A +137.1% Details
4/27/11 Q111 $0.92$0.88 +$0.04$2.72B$2.65B = +105.4% Details
7/27/11 Q211 $0.99$0.98 +$0.01$2.9B$2.84B = +93.8% Details
10/26/11 Q311 $1.07$1.07 $0.00$2.97B$3B = +124.1% Details
2/1/12 Q411 $1.18$1.15 +$0.03$3.13B$3.08B +125.5% Details
4/25/12 Q112 $1.17$1.10 +$0.07$3.1B$2.97B +126.2% Details
7/25/12 Q212 $1.22$1.16 +$0.06$3.11B$3.05B +139.7% Details
10/24/12 Q312 $1.19$1.16 +$0.03$3.09B$2.99B +107.1% Details